nodes	percent_of_prediction	percent_of_DWPC	metapath
Everolimus—CYP3A4—Disulfiram—alcohol dependence	0.138	0.584	CbGbCtD
Everolimus—CYP3A4—Citalopram—alcohol dependence	0.0986	0.416	CbGbCtD
Everolimus—MTOR—brainstem—alcohol dependence	0.0066	0.053	CbGeAlD
Everolimus—MTOR—forebrain—alcohol dependence	0.00637	0.0511	CbGeAlD
Everolimus—FKBP1A—Alpha-synuclein signaling—MAOB—alcohol dependence	0.00596	0.0807	CbGpPWpGaD
Everolimus—FKBP1A—forebrain—alcohol dependence	0.00573	0.046	CbGeAlD
Everolimus—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00541	0.0733	CbGpPWpGaD
Everolimus—MTOR—cardiovascular system—alcohol dependence	0.00539	0.0432	CbGeAlD
Everolimus—FKBP1A—adrenal cortex—alcohol dependence	0.00531	0.0426	CbGeAlD
Everolimus—MTOR—pancreas—alcohol dependence	0.00524	0.042	CbGeAlD
Everolimus—MTOR—gonad—alcohol dependence	0.00489	0.0392	CbGeAlD
Everolimus—FKBP1A—cardiovascular system—alcohol dependence	0.00485	0.0389	CbGeAlD
Everolimus—FKBP1A—pancreas—alcohol dependence	0.00471	0.0378	CbGeAlD
Everolimus—MTOR—digestive system—alcohol dependence	0.00447	0.0359	CbGeAlD
Everolimus—FKBP1A—gonad—alcohol dependence	0.0044	0.0353	CbGeAlD
Everolimus—MTOR—blood—alcohol dependence	0.00426	0.0342	CbGeAlD
Everolimus—FKBP1A—digestive system—alcohol dependence	0.00402	0.0323	CbGeAlD
Everolimus—FKBP1A—Alpha-synuclein signaling—SLC6A3—alcohol dependence	0.00395	0.0535	CbGpPWpGaD
Everolimus—FKBP1A—blood—alcohol dependence	0.00383	0.0308	CbGeAlD
Everolimus—FKBP1A—midbrain—alcohol dependence	0.00379	0.0304	CbGeAlD
Everolimus—MTOR—endocrine gland—alcohol dependence	0.0037	0.0297	CbGeAlD
Everolimus—MTOR—testis—alcohol dependence	0.00353	0.0283	CbGeAlD
Everolimus—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00347	0.047	CbGpPWpGaD
Everolimus—MTOR—nervous system—alcohol dependence	0.00346	0.0278	CbGeAlD
Everolimus—MTOR—liver—alcohol dependence	0.00333	0.0267	CbGeAlD
Everolimus—MTOR—central nervous system—alcohol dependence	0.00333	0.0267	CbGeAlD
Everolimus—FKBP1A—endocrine gland—alcohol dependence	0.00332	0.0267	CbGeAlD
Everolimus—MTOR—cerebellum—alcohol dependence	0.00326	0.0261	CbGeAlD
Everolimus—FKBP1A—testis—alcohol dependence	0.00317	0.0254	CbGeAlD
Everolimus—FKBP1A—nervous system—alcohol dependence	0.00311	0.025	CbGeAlD
Everolimus—FKBP1A—liver—alcohol dependence	0.003	0.024	CbGeAlD
Everolimus—FKBP1A—central nervous system—alcohol dependence	0.003	0.024	CbGeAlD
Everolimus—FKBP1A—cerebellum—alcohol dependence	0.00293	0.0235	CbGeAlD
Everolimus—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00287	0.0389	CbGpPWpGaD
Everolimus—MTOR—brain—alcohol dependence	0.00264	0.0212	CbGeAlD
Everolimus—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00244	0.0331	CbGpPWpGaD
Everolimus—FKBP1A—brain—alcohol dependence	0.00238	0.0191	CbGeAlD
Everolimus—FKBP1A—Spinal Cord Injury—PDYN—alcohol dependence	0.00229	0.0311	CbGpPWpGaD
Everolimus—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00208	0.0281	CbGpPWpGaD
Everolimus—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00183	0.0247	CbGpPWpGaD
Everolimus—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00182	0.0247	CbGpPWpGaD
Everolimus—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00173	0.0235	CbGpPWpGaD
Everolimus—MTOR—IL4-mediated signaling events—OPRM1—alcohol dependence	0.00173	0.0235	CbGpPWpGaD
Everolimus—FKBP1A—Calcium Regulation in the Cardiac Cell—CHRM2—alcohol dependence	0.00166	0.0225	CbGpPWpGaD
Everolimus—MTOR—ErbB1 downstream signaling—WASF2—alcohol dependence	0.00132	0.0178	CbGpPWpGaD
Everolimus—CYP3A4—digestive system—alcohol dependence	0.00131	0.0105	CbGeAlD
Everolimus—MTOR—VEGFA-VEGFR2 Pathway—WASF2—alcohol dependence	0.0013	0.0176	CbGpPWpGaD
Everolimus—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00128	0.0174	CbGpPWpGaD
Everolimus—CYP3A4—blood—alcohol dependence	0.00125	0.01	CbGeAlD
Everolimus—MTOR—VEGFA-VEGFR2 Pathway—WASF1—alcohol dependence	0.00124	0.0169	CbGpPWpGaD
Everolimus—MTOR—Signaling by VEGF—WASF2—alcohol dependence	0.00122	0.0166	CbGpPWpGaD
Everolimus—MTOR—Signaling by VEGF—WASF1—alcohol dependence	0.00117	0.0159	CbGpPWpGaD
Everolimus—CYP3A4—endocrine gland—alcohol dependence	0.00109	0.00872	CbGeAlD
Everolimus—MTOR—HSF1-dependent transactivation—EP300—alcohol dependence	0.00106	0.0144	CbGpPWpGaD
Everolimus—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00103	0.0139	CbGpPWpGaD
Everolimus—CYP3A4—nervous system—alcohol dependence	0.00102	0.00816	CbGeAlD
Everolimus—CYP3A4—liver—alcohol dependence	0.00098	0.00786	CbGeAlD
Everolimus—CYP3A4—central nervous system—alcohol dependence	0.000979	0.00785	CbGeAlD
Everolimus—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000976	0.0132	CbGpPWpGaD
Everolimus—FKBP1A—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—alcohol dependence	0.000923	0.0125	CbGpPWpGaD
Everolimus—FKBP1A—TGF-beta Receptor Signaling—EP300—alcohol dependence	0.000923	0.0125	CbGpPWpGaD
Everolimus—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000858	0.0116	CbGpPWpGaD
Everolimus—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000825	0.0112	CbGpPWpGaD
Everolimus—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000821	0.0111	CbGpPWpGaD
Everolimus—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000809	0.011	CbGpPWpGaD
Everolimus—Lethargy—Citalopram—alcohol dependence	0.000759	0.00135	CcSEcCtD
Everolimus—Eye disorder—Naltrexone—alcohol dependence	0.000759	0.00135	CcSEcCtD
Everolimus—Alopecia—Acamprosate—alcohol dependence	0.000759	0.00134	CcSEcCtD
Everolimus—Cardiac disorder—Naltrexone—alcohol dependence	0.000754	0.00134	CcSEcCtD
Everolimus—Mental disorder—Acamprosate—alcohol dependence	0.000752	0.00133	CcSEcCtD
Everolimus—Malnutrition—Acamprosate—alcohol dependence	0.000748	0.00132	CcSEcCtD
Everolimus—Hyponatraemia—Citalopram—alcohol dependence	0.000747	0.00132	CcSEcCtD
Everolimus—Pain in extremity—Citalopram—alcohol dependence	0.000744	0.00132	CcSEcCtD
Everolimus—Angiopathy—Naltrexone—alcohol dependence	0.000737	0.00131	CcSEcCtD
Everolimus—Flatulence—Acamprosate—alcohol dependence	0.000737	0.00131	CcSEcCtD
Everolimus—Immune system disorder—Naltrexone—alcohol dependence	0.000734	0.0013	CcSEcCtD
Everolimus—Migraine—Citalopram—alcohol dependence	0.000733	0.0013	CcSEcCtD
Everolimus—Mediastinal disorder—Naltrexone—alcohol dependence	0.000732	0.0013	CcSEcCtD
Everolimus—Dysgeusia—Acamprosate—alcohol dependence	0.000732	0.0013	CcSEcCtD
Everolimus—Chills—Naltrexone—alcohol dependence	0.000729	0.00129	CcSEcCtD
Everolimus—Back pain—Acamprosate—alcohol dependence	0.000723	0.00128	CcSEcCtD
Everolimus—Muscle spasms—Acamprosate—alcohol dependence	0.000719	0.00127	CcSEcCtD
Everolimus—Alopecia—Naltrexone—alcohol dependence	0.000718	0.00127	CcSEcCtD
Everolimus—Mental disorder—Naltrexone—alcohol dependence	0.000712	0.00126	CcSEcCtD
Everolimus—Irritability—Citalopram—alcohol dependence	0.00071	0.00126	CcSEcCtD
Everolimus—Urinary retention—Citalopram—alcohol dependence	0.000708	0.00125	CcSEcCtD
Everolimus—Cardiac arrest—Citalopram—alcohol dependence	0.000708	0.00125	CcSEcCtD
Everolimus—Malnutrition—Naltrexone—alcohol dependence	0.000707	0.00125	CcSEcCtD
Everolimus—Tremor—Acamprosate—alcohol dependence	0.0007	0.00124	CcSEcCtD
Everolimus—Flatulence—Naltrexone—alcohol dependence	0.000697	0.00123	CcSEcCtD
Everolimus—Ill-defined disorder—Acamprosate—alcohol dependence	0.000694	0.00123	CcSEcCtD
Everolimus—Dysgeusia—Naltrexone—alcohol dependence	0.000693	0.00123	CcSEcCtD
Everolimus—Dehydration—Citalopram—alcohol dependence	0.000692	0.00123	CcSEcCtD
Everolimus—Anaemia—Acamprosate—alcohol dependence	0.000691	0.00122	CcSEcCtD
Everolimus—MTOR—Cellular response to heat stress—EP300—alcohol dependence	0.000688	0.00932	CbGpPWpGaD
Everolimus—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000688	0.00932	CbGpPWpGaD
Everolimus—Liver function test abnormal—Citalopram—alcohol dependence	0.000687	0.00122	CcSEcCtD
Everolimus—Agitation—Acamprosate—alcohol dependence	0.000687	0.00122	CcSEcCtD
Everolimus—Back pain—Naltrexone—alcohol dependence	0.000684	0.00121	CcSEcCtD
Everolimus—Angioedema—Acamprosate—alcohol dependence	0.000683	0.00121	CcSEcCtD
Everolimus—Dry skin—Citalopram—alcohol dependence	0.000682	0.00121	CcSEcCtD
Everolimus—Muscle spasms—Naltrexone—alcohol dependence	0.00068	0.0012	CcSEcCtD
Everolimus—Abdominal pain upper—Citalopram—alcohol dependence	0.00068	0.0012	CcSEcCtD
Everolimus—Hypokalaemia—Citalopram—alcohol dependence	0.000677	0.0012	CcSEcCtD
Everolimus—Malaise—Acamprosate—alcohol dependence	0.000674	0.00119	CcSEcCtD
Everolimus—Breast disorder—Citalopram—alcohol dependence	0.000673	0.00119	CcSEcCtD
Everolimus—Syncope—Acamprosate—alcohol dependence	0.00067	0.00119	CcSEcCtD
Everolimus—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00067	0.00119	CcSEcCtD
Everolimus—Leukopenia—Acamprosate—alcohol dependence	0.000669	0.00119	CcSEcCtD
Everolimus—Vision blurred—Naltrexone—alcohol dependence	0.000667	0.00118	CcSEcCtD
Everolimus—Nasopharyngitis—Citalopram—alcohol dependence	0.000666	0.00118	CcSEcCtD
Everolimus—Tremor—Naltrexone—alcohol dependence	0.000663	0.00117	CcSEcCtD
Everolimus—Palpitations—Acamprosate—alcohol dependence	0.000661	0.00117	CcSEcCtD
Everolimus—MTOR—BDNF signaling pathway—GRIN2B—alcohol dependence	0.000659	0.00893	CbGpPWpGaD
Everolimus—Gastritis—Citalopram—alcohol dependence	0.000659	0.00117	CcSEcCtD
Everolimus—Loss of consciousness—Acamprosate—alcohol dependence	0.000657	0.00116	CcSEcCtD
Everolimus—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000656	0.00116	CcSEcCtD
Everolimus—Muscular weakness—Citalopram—alcohol dependence	0.000656	0.00116	CcSEcCtD
Everolimus—Ill-defined disorder—Naltrexone—alcohol dependence	0.000656	0.00116	CcSEcCtD
Everolimus—MTOR—BDNF signaling pathway—CNR1—alcohol dependence	0.000654	0.00887	CbGpPWpGaD
Everolimus—Cough—Acamprosate—alcohol dependence	0.000652	0.00116	CcSEcCtD
Everolimus—Agitation—Naltrexone—alcohol dependence	0.00065	0.00115	CcSEcCtD
Everolimus—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000648	0.00878	CbGpPWpGaD
Everolimus—Convulsion—Acamprosate—alcohol dependence	0.000648	0.00115	CcSEcCtD
Everolimus—Abdominal distension—Citalopram—alcohol dependence	0.000648	0.00115	CcSEcCtD
Everolimus—Angioedema—Naltrexone—alcohol dependence	0.000646	0.00114	CcSEcCtD
Everolimus—Hypertension—Acamprosate—alcohol dependence	0.000646	0.00114	CcSEcCtD
Everolimus—Influenza—Citalopram—alcohol dependence	0.000643	0.00114	CcSEcCtD
Everolimus—Dysphagia—Citalopram—alcohol dependence	0.000643	0.00114	CcSEcCtD
Everolimus—Malaise—Naltrexone—alcohol dependence	0.000638	0.00113	CcSEcCtD
Everolimus—Arthralgia—Acamprosate—alcohol dependence	0.000637	0.00113	CcSEcCtD
Everolimus—Myalgia—Acamprosate—alcohol dependence	0.000637	0.00113	CcSEcCtD
Everolimus—Chest pain—Acamprosate—alcohol dependence	0.000637	0.00113	CcSEcCtD
Everolimus—Syncope—Naltrexone—alcohol dependence	0.000634	0.00112	CcSEcCtD
Everolimus—Anxiety—Acamprosate—alcohol dependence	0.000634	0.00112	CcSEcCtD
Everolimus—Bronchospasm—Citalopram—alcohol dependence	0.000633	0.00112	CcSEcCtD
Everolimus—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000632	0.00112	CcSEcCtD
Everolimus—Pancreatitis—Citalopram—alcohol dependence	0.000631	0.00112	CcSEcCtD
Everolimus—Discomfort—Acamprosate—alcohol dependence	0.000629	0.00111	CcSEcCtD
Everolimus—Angina pectoris—Citalopram—alcohol dependence	0.000627	0.00111	CcSEcCtD
Everolimus—Palpitations—Naltrexone—alcohol dependence	0.000625	0.00111	CcSEcCtD
Everolimus—MTOR—IFN-gamma pathway—EP300—alcohol dependence	0.000623	0.00844	CbGpPWpGaD
Everolimus—Dry mouth—Acamprosate—alcohol dependence	0.000623	0.0011	CcSEcCtD
Everolimus—Loss of consciousness—Naltrexone—alcohol dependence	0.000622	0.0011	CcSEcCtD
Everolimus—Bronchitis—Citalopram—alcohol dependence	0.000619	0.0011	CcSEcCtD
Everolimus—Cough—Naltrexone—alcohol dependence	0.000617	0.00109	CcSEcCtD
Everolimus—Convulsion—Naltrexone—alcohol dependence	0.000613	0.00109	CcSEcCtD
Everolimus—Pancytopenia—Citalopram—alcohol dependence	0.000611	0.00108	CcSEcCtD
Everolimus—Hypertension—Naltrexone—alcohol dependence	0.000611	0.00108	CcSEcCtD
Everolimus—Infection—Acamprosate—alcohol dependence	0.000606	0.00107	CcSEcCtD
Everolimus—Myalgia—Naltrexone—alcohol dependence	0.000602	0.00107	CcSEcCtD
Everolimus—Arthralgia—Naltrexone—alcohol dependence	0.000602	0.00107	CcSEcCtD
Everolimus—Chest pain—Naltrexone—alcohol dependence	0.000602	0.00107	CcSEcCtD
Everolimus—Dysuria—Citalopram—alcohol dependence	0.000602	0.00107	CcSEcCtD
Everolimus—Shock—Acamprosate—alcohol dependence	0.0006	0.00106	CcSEcCtD
Everolimus—Anxiety—Naltrexone—alcohol dependence	0.0006	0.00106	CcSEcCtD
Everolimus—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000598	0.00106	CcSEcCtD
Everolimus—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000598	0.00106	CcSEcCtD
Everolimus—Thrombocytopenia—Acamprosate—alcohol dependence	0.000597	0.00106	CcSEcCtD
Everolimus—Tachycardia—Acamprosate—alcohol dependence	0.000596	0.00105	CcSEcCtD
Everolimus—Discomfort—Naltrexone—alcohol dependence	0.000595	0.00105	CcSEcCtD
Everolimus—Pollakiuria—Citalopram—alcohol dependence	0.000594	0.00105	CcSEcCtD
Everolimus—Skin disorder—Acamprosate—alcohol dependence	0.000593	0.00105	CcSEcCtD
Everolimus—Erectile dysfunction—Citalopram—alcohol dependence	0.000592	0.00105	CcSEcCtD
Everolimus—Hyperhidrosis—Acamprosate—alcohol dependence	0.00059	0.00104	CcSEcCtD
Everolimus—Dry mouth—Naltrexone—alcohol dependence	0.000589	0.00104	CcSEcCtD
Everolimus—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000585	0.00792	CbGpPWpGaD
Everolimus—Weight decreased—Citalopram—alcohol dependence	0.000582	0.00103	CcSEcCtD
Everolimus—Anorexia—Acamprosate—alcohol dependence	0.000582	0.00103	CcSEcCtD
Everolimus—Hyperglycaemia—Citalopram—alcohol dependence	0.00058	0.00103	CcSEcCtD
Everolimus—Oedema—Naltrexone—alcohol dependence	0.000577	0.00102	CcSEcCtD
Everolimus—Pneumonia—Citalopram—alcohol dependence	0.000577	0.00102	CcSEcCtD
Everolimus—Infection—Naltrexone—alcohol dependence	0.000574	0.00102	CcSEcCtD
Everolimus—Infestation—Citalopram—alcohol dependence	0.000574	0.00102	CcSEcCtD
Everolimus—Infestation NOS—Citalopram—alcohol dependence	0.000574	0.00102	CcSEcCtD
Everolimus—Hypotension—Acamprosate—alcohol dependence	0.00057	0.00101	CcSEcCtD
Everolimus—Shock—Naltrexone—alcohol dependence	0.000568	0.00101	CcSEcCtD
Everolimus—Nervous system disorder—Naltrexone—alcohol dependence	0.000566	0.001	CcSEcCtD
Everolimus—Acute coronary syndrome—Citalopram—alcohol dependence	0.000565	0.001	CcSEcCtD
Everolimus—Tachycardia—Naltrexone—alcohol dependence	0.000563	0.000998	CcSEcCtD
Everolimus—Myocardial infarction—Citalopram—alcohol dependence	0.000562	0.000996	CcSEcCtD
Everolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000561	0.0076	CbGpPWpGaD
Everolimus—Skin disorder—Naltrexone—alcohol dependence	0.000561	0.000993	CcSEcCtD
Everolimus—Stomatitis—Citalopram—alcohol dependence	0.000559	0.00099	CcSEcCtD
Everolimus—Jaundice—Citalopram—alcohol dependence	0.000559	0.00099	CcSEcCtD
Everolimus—Hyperhidrosis—Naltrexone—alcohol dependence	0.000558	0.000989	CcSEcCtD
Everolimus—Conjunctivitis—Citalopram—alcohol dependence	0.000558	0.000988	CcSEcCtD
Everolimus—Urinary tract infection—Citalopram—alcohol dependence	0.000558	0.000988	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000556	0.000985	CcSEcCtD
Everolimus—Insomnia—Acamprosate—alcohol dependence	0.000552	0.000978	CcSEcCtD
Everolimus—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000551	0.00747	CbGpPWpGaD
Everolimus—Anorexia—Naltrexone—alcohol dependence	0.00055	0.000975	CcSEcCtD
Everolimus—Paraesthesia—Acamprosate—alcohol dependence	0.000548	0.000971	CcSEcCtD
Everolimus—Haematuria—Citalopram—alcohol dependence	0.000547	0.000969	CcSEcCtD
Everolimus—Dyspnoea—Acamprosate—alcohol dependence	0.000544	0.000964	CcSEcCtD
Everolimus—Somnolence—Acamprosate—alcohol dependence	0.000542	0.000961	CcSEcCtD
Everolimus—Hepatobiliary disease—Citalopram—alcohol dependence	0.000542	0.000961	CcSEcCtD
Everolimus—Epistaxis—Citalopram—alcohol dependence	0.000541	0.000958	CcSEcCtD
Everolimus—Sinusitis—Citalopram—alcohol dependence	0.000538	0.000953	CcSEcCtD
Everolimus—Dyspepsia—Acamprosate—alcohol dependence	0.000537	0.000951	CcSEcCtD
Everolimus—Decreased appetite—Acamprosate—alcohol dependence	0.00053	0.00094	CcSEcCtD
Everolimus—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000527	0.000933	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000526	0.000932	CcSEcCtD
Everolimus—Insomnia—Naltrexone—alcohol dependence	0.000522	0.000925	CcSEcCtD
Everolimus—Constipation—Acamprosate—alcohol dependence	0.000522	0.000924	CcSEcCtD
Everolimus—Pain—Acamprosate—alcohol dependence	0.000522	0.000924	CcSEcCtD
Everolimus—Paraesthesia—Naltrexone—alcohol dependence	0.000518	0.000918	CcSEcCtD
Everolimus—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000518	0.00702	CbGpPWpGaD
Everolimus—Haemoglobin—Citalopram—alcohol dependence	0.000517	0.000917	CcSEcCtD
Everolimus—Rhinitis—Citalopram—alcohol dependence	0.000516	0.000914	CcSEcCtD
Everolimus—Haemorrhage—Citalopram—alcohol dependence	0.000515	0.000912	CcSEcCtD
Everolimus—Hepatitis—Citalopram—alcohol dependence	0.000515	0.000912	CcSEcCtD
Everolimus—Dyspnoea—Naltrexone—alcohol dependence	0.000515	0.000912	CcSEcCtD
Everolimus—Somnolence—Naltrexone—alcohol dependence	0.000513	0.000909	CcSEcCtD
Everolimus—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000513	0.00695	CbGpPWpGaD
Everolimus—Hallucination—Citalopram—alcohol dependence	0.000512	0.000907	CcSEcCtD
Everolimus—Hypoaesthesia—Citalopram—alcohol dependence	0.000512	0.000907	CcSEcCtD
Everolimus—Pharyngitis—Citalopram—alcohol dependence	0.000511	0.000905	CcSEcCtD
Everolimus—Urinary tract disorder—Citalopram—alcohol dependence	0.000508	0.000901	CcSEcCtD
Everolimus—Oedema peripheral—Citalopram—alcohol dependence	0.000507	0.000898	CcSEcCtD
Everolimus—Connective tissue disorder—Citalopram—alcohol dependence	0.000506	0.000896	CcSEcCtD
Everolimus—Urethral disorder—Citalopram—alcohol dependence	0.000505	0.000894	CcSEcCtD
Everolimus—Feeling abnormal—Acamprosate—alcohol dependence	0.000503	0.000891	CcSEcCtD
Everolimus—Decreased appetite—Naltrexone—alcohol dependence	0.000502	0.000889	CcSEcCtD
Everolimus—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000499	0.000884	CcSEcCtD
Everolimus—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000498	0.000883	CcSEcCtD
Everolimus—Fatigue—Naltrexone—alcohol dependence	0.000498	0.000882	CcSEcCtD
Everolimus—Pain—Naltrexone—alcohol dependence	0.000494	0.000875	CcSEcCtD
Everolimus—Constipation—Naltrexone—alcohol dependence	0.000494	0.000875	CcSEcCtD
Everolimus—Abdominal pain—Acamprosate—alcohol dependence	0.000482	0.000854	CcSEcCtD
Everolimus—Body temperature increased—Acamprosate—alcohol dependence	0.000482	0.000854	CcSEcCtD
Everolimus—Eye disorder—Citalopram—alcohol dependence	0.000481	0.000852	CcSEcCtD
Everolimus—Cardiac disorder—Citalopram—alcohol dependence	0.000478	0.000846	CcSEcCtD
Everolimus—Flushing—Citalopram—alcohol dependence	0.000478	0.000846	CcSEcCtD
Everolimus—Feeling abnormal—Naltrexone—alcohol dependence	0.000476	0.000843	CcSEcCtD
Everolimus—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000472	0.000836	CcSEcCtD
Everolimus—Angiopathy—Citalopram—alcohol dependence	0.000467	0.000827	CcSEcCtD
Everolimus—Immune system disorder—Citalopram—alcohol dependence	0.000465	0.000824	CcSEcCtD
Everolimus—Mediastinal disorder—Citalopram—alcohol dependence	0.000464	0.000822	CcSEcCtD
Everolimus—Chills—Citalopram—alcohol dependence	0.000462	0.000818	CcSEcCtD
Everolimus—Abdominal pain—Naltrexone—alcohol dependence	0.000456	0.000808	CcSEcCtD
Everolimus—Body temperature increased—Naltrexone—alcohol dependence	0.000456	0.000808	CcSEcCtD
Everolimus—Alopecia—Citalopram—alcohol dependence	0.000455	0.000806	CcSEcCtD
Everolimus—Mental disorder—Citalopram—alcohol dependence	0.000451	0.000799	CcSEcCtD
Everolimus—Hypersensitivity—Acamprosate—alcohol dependence	0.00045	0.000796	CcSEcCtD
Everolimus—Erythema—Citalopram—alcohol dependence	0.000448	0.000794	CcSEcCtD
Everolimus—Malnutrition—Citalopram—alcohol dependence	0.000448	0.000794	CcSEcCtD
Everolimus—Flatulence—Citalopram—alcohol dependence	0.000442	0.000782	CcSEcCtD
Everolimus—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000441	0.00597	CbGpPWpGaD
Everolimus—Dysgeusia—Citalopram—alcohol dependence	0.000439	0.000777	CcSEcCtD
Everolimus—Asthenia—Acamprosate—alcohol dependence	0.000438	0.000775	CcSEcCtD
Everolimus—Back pain—Citalopram—alcohol dependence	0.000434	0.000768	CcSEcCtD
Everolimus—Pruritus—Acamprosate—alcohol dependence	0.000432	0.000765	CcSEcCtD
Everolimus—Muscle spasms—Citalopram—alcohol dependence	0.000431	0.000763	CcSEcCtD
Everolimus—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.00043	0.00582	CbGpPWpGaD
Everolimus—Hypersensitivity—Naltrexone—alcohol dependence	0.000425	0.000753	CcSEcCtD
Everolimus—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000425	0.00576	CbGpPWpGaD
Everolimus—Vision blurred—Citalopram—alcohol dependence	0.000422	0.000748	CcSEcCtD
Everolimus—Tremor—Citalopram—alcohol dependence	0.00042	0.000744	CcSEcCtD
Everolimus—Diarrhoea—Acamprosate—alcohol dependence	0.000417	0.00074	CcSEcCtD
Everolimus—Ill-defined disorder—Citalopram—alcohol dependence	0.000416	0.000737	CcSEcCtD
Everolimus—Anaemia—Citalopram—alcohol dependence	0.000414	0.000734	CcSEcCtD
Everolimus—Asthenia—Naltrexone—alcohol dependence	0.000414	0.000734	CcSEcCtD
Everolimus—Agitation—Citalopram—alcohol dependence	0.000412	0.00073	CcSEcCtD
Everolimus—Angioedema—Citalopram—alcohol dependence	0.00041	0.000725	CcSEcCtD
Everolimus—Pruritus—Naltrexone—alcohol dependence	0.000408	0.000724	CcSEcCtD
Everolimus—Malaise—Citalopram—alcohol dependence	0.000404	0.000716	CcSEcCtD
Everolimus—Dizziness—Acamprosate—alcohol dependence	0.000404	0.000715	CcSEcCtD
Everolimus—Syncope—Citalopram—alcohol dependence	0.000402	0.000712	CcSEcCtD
Everolimus—Leukopenia—Citalopram—alcohol dependence	0.000401	0.000711	CcSEcCtD
Everolimus—Palpitations—Citalopram—alcohol dependence	0.000396	0.000702	CcSEcCtD
Everolimus—Diarrhoea—Naltrexone—alcohol dependence	0.000395	0.0007	CcSEcCtD
Everolimus—Loss of consciousness—Citalopram—alcohol dependence	0.000394	0.000698	CcSEcCtD
Everolimus—Cough—Citalopram—alcohol dependence	0.000391	0.000693	CcSEcCtD
Everolimus—Convulsion—Citalopram—alcohol dependence	0.000388	0.000688	CcSEcCtD
Everolimus—Vomiting—Acamprosate—alcohol dependence	0.000388	0.000687	CcSEcCtD
Everolimus—Hypertension—Citalopram—alcohol dependence	0.000387	0.000685	CcSEcCtD
Everolimus—Rash—Acamprosate—alcohol dependence	0.000385	0.000682	CcSEcCtD
Everolimus—Dermatitis—Acamprosate—alcohol dependence	0.000384	0.000681	CcSEcCtD
Everolimus—Headache—Acamprosate—alcohol dependence	0.000382	0.000677	CcSEcCtD
Everolimus—Dizziness—Naltrexone—alcohol dependence	0.000382	0.000676	CcSEcCtD
Everolimus—Chest pain—Citalopram—alcohol dependence	0.000382	0.000676	CcSEcCtD
Everolimus—Myalgia—Citalopram—alcohol dependence	0.000382	0.000676	CcSEcCtD
Everolimus—Arthralgia—Citalopram—alcohol dependence	0.000382	0.000676	CcSEcCtD
Everolimus—Anxiety—Citalopram—alcohol dependence	0.00038	0.000674	CcSEcCtD
Everolimus—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000379	0.000671	CcSEcCtD
Everolimus—Discomfort—Citalopram—alcohol dependence	0.000377	0.000668	CcSEcCtD
Everolimus—FKBP1A—Signaling Pathways—OPRK1—alcohol dependence	0.000377	0.0051	CbGpPWpGaD
Everolimus—Dry mouth—Citalopram—alcohol dependence	0.000373	0.000661	CcSEcCtD
Everolimus—Vomiting—Naltrexone—alcohol dependence	0.000367	0.00065	CcSEcCtD
Everolimus—Oedema—Citalopram—alcohol dependence	0.000366	0.000648	CcSEcCtD
Everolimus—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000365	0.00495	CbGpPWpGaD
Everolimus—Rash—Naltrexone—alcohol dependence	0.000364	0.000645	CcSEcCtD
Everolimus—Dermatitis—Naltrexone—alcohol dependence	0.000364	0.000644	CcSEcCtD
Everolimus—Infection—Citalopram—alcohol dependence	0.000363	0.000644	CcSEcCtD
Everolimus—Nausea—Acamprosate—alcohol dependence	0.000362	0.000642	CcSEcCtD
Everolimus—Headache—Naltrexone—alcohol dependence	0.000362	0.000641	CcSEcCtD
Everolimus—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000361	0.00489	CbGpPWpGaD
Everolimus—Shock—Citalopram—alcohol dependence	0.00036	0.000637	CcSEcCtD
Everolimus—Nervous system disorder—Citalopram—alcohol dependence	0.000359	0.000635	CcSEcCtD
Everolimus—Thrombocytopenia—Citalopram—alcohol dependence	0.000358	0.000634	CcSEcCtD
Everolimus—Tachycardia—Citalopram—alcohol dependence	0.000357	0.000632	CcSEcCtD
Everolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000356	0.00483	CbGpPWpGaD
Everolimus—Skin disorder—Citalopram—alcohol dependence	0.000355	0.000629	CcSEcCtD
Everolimus—Hyperhidrosis—Citalopram—alcohol dependence	0.000354	0.000626	CcSEcCtD
Everolimus—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000352	0.00476	CbGpPWpGaD
Everolimus—Anorexia—Citalopram—alcohol dependence	0.000349	0.000618	CcSEcCtD
Everolimus—Nausea—Naltrexone—alcohol dependence	0.000343	0.000607	CcSEcCtD
Everolimus—Hypotension—Citalopram—alcohol dependence	0.000342	0.000605	CcSEcCtD
Everolimus—MTOR—Innate Immune System—WASF2—alcohol dependence	0.000337	0.00457	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000336	0.00455	CbGpPWpGaD
Everolimus—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000333	0.00059	CcSEcCtD
Everolimus—Insomnia—Citalopram—alcohol dependence	0.000331	0.000586	CcSEcCtD
Everolimus—Paraesthesia—Citalopram—alcohol dependence	0.000328	0.000582	CcSEcCtD
Everolimus—Dyspnoea—Citalopram—alcohol dependence	0.000326	0.000578	CcSEcCtD
Everolimus—Somnolence—Citalopram—alcohol dependence	0.000325	0.000576	CcSEcCtD
Everolimus—MTOR—Innate Immune System—WASF1—alcohol dependence	0.000323	0.00438	CbGpPWpGaD
Everolimus—Dyspepsia—Citalopram—alcohol dependence	0.000322	0.00057	CcSEcCtD
Everolimus—Decreased appetite—Citalopram—alcohol dependence	0.000318	0.000563	CcSEcCtD
Everolimus—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000316	0.000559	CcSEcCtD
Everolimus—Fatigue—Citalopram—alcohol dependence	0.000315	0.000559	CcSEcCtD
Everolimus—Constipation—Citalopram—alcohol dependence	0.000313	0.000554	CcSEcCtD
Everolimus—Pain—Citalopram—alcohol dependence	0.000313	0.000554	CcSEcCtD
Everolimus—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000311	0.00421	CbGpPWpGaD
Everolimus—Feeling abnormal—Citalopram—alcohol dependence	0.000301	0.000534	CcSEcCtD
Everolimus—Gastrointestinal pain—Citalopram—alcohol dependence	0.000299	0.00053	CcSEcCtD
Everolimus—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000298	0.00403	CbGpPWpGaD
Everolimus—Abdominal pain—Citalopram—alcohol dependence	0.000289	0.000512	CcSEcCtD
Everolimus—Body temperature increased—Citalopram—alcohol dependence	0.000289	0.000512	CcSEcCtD
Everolimus—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000289	0.00391	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000272	0.00369	CbGpPWpGaD
Everolimus—Hypersensitivity—Citalopram—alcohol dependence	0.00027	0.000477	CcSEcCtD
Everolimus—Asthenia—Citalopram—alcohol dependence	0.000262	0.000465	CcSEcCtD
Everolimus—Pruritus—Citalopram—alcohol dependence	0.000259	0.000458	CcSEcCtD
Everolimus—FKBP1A—Signaling Pathways—OPRD1—alcohol dependence	0.000253	0.00343	CbGpPWpGaD
Everolimus—Diarrhoea—Citalopram—alcohol dependence	0.00025	0.000443	CcSEcCtD
Everolimus—FKBP1A—Signaling Pathways—PDYN—alcohol dependence	0.000243	0.00329	CbGpPWpGaD
Everolimus—Dizziness—Citalopram—alcohol dependence	0.000242	0.000428	CcSEcCtD
Everolimus—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000238	0.00322	CbGpPWpGaD
Everolimus—Vomiting—Citalopram—alcohol dependence	0.000233	0.000412	CcSEcCtD
Everolimus—Rash—Citalopram—alcohol dependence	0.000231	0.000409	CcSEcCtD
Everolimus—Dermatitis—Citalopram—alcohol dependence	0.00023	0.000408	CcSEcCtD
Everolimus—Headache—Citalopram—alcohol dependence	0.000229	0.000406	CcSEcCtD
Everolimus—MTOR—Integrated Breast Cancer Pathway—EP300—alcohol dependence	0.000228	0.00309	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000226	0.00306	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—WASF2—alcohol dependence	0.000226	0.00306	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CRHR1—alcohol dependence	0.000226	0.00306	CbGpPWpGaD
Everolimus—FKBP1A—Disease—GOT2—alcohol dependence	0.000223	0.00303	CbGpPWpGaD
Everolimus—Nausea—Citalopram—alcohol dependence	0.000217	0.000385	CcSEcCtD
Everolimus—FKBP1A—Signaling Pathways—WASF1—alcohol dependence	0.000216	0.00293	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CHRM2—alcohol dependence	0.000212	0.00287	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—OPRK1—alcohol dependence	0.000212	0.00287	CbGpPWpGaD
Everolimus—MTOR—Immune System—WASF2—alcohol dependence	0.000196	0.00266	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—OPRM1—alcohol dependence	0.000195	0.00264	CbGpPWpGaD
Everolimus—FKBP1A—Disease—GOT1—alcohol dependence	0.000193	0.00261	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000192	0.0026	CbGpPWpGaD
Everolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000191	0.00259	CbGpPWpGaD
Everolimus—MTOR—Immune System—WASF1—alcohol dependence	0.000188	0.00255	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NPY—alcohol dependence	0.000179	0.00243	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—HTR1B—alcohol dependence	0.000173	0.00234	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CRH—alcohol dependence	0.000173	0.00234	CbGpPWpGaD
Everolimus—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000155	0.0021	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000153	0.00208	CbGpPWpGaD
Everolimus—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000151	0.00205	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—DRD4—alcohol dependence	0.000151	0.00205	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—EP300—alcohol dependence	0.000146	0.00198	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CNR1—alcohol dependence	0.000144	0.00196	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—OPRD1—alcohol dependence	0.000142	0.00193	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000141	0.00191	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—HTR7—alcohol dependence	0.000141	0.00191	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—DRD2—alcohol dependence	0.000141	0.00191	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PDYN—alcohol dependence	0.000136	0.00185	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—WASF2—alcohol dependence	0.000127	0.00172	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CRHR1—alcohol dependence	0.000127	0.00172	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—MAOA—alcohol dependence	0.000126	0.00171	CbGpPWpGaD
Everolimus—MTOR—Disease—GOT2—alcohol dependence	0.000126	0.0017	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—WASF1—alcohol dependence	0.000122	0.00165	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CHRM2—alcohol dependence	0.000119	0.00162	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—AVP—alcohol dependence	0.000119	0.00161	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—OPRM1—alcohol dependence	0.00011	0.00148	CbGpPWpGaD
Everolimus—MTOR—Disease—GOT1—alcohol dependence	0.000108	0.00147	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NPY—alcohol dependence	0.000101	0.00137	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—HTR2A—alcohol dependence	9.86e-05	0.00134	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HTR1B—alcohol dependence	9.73e-05	0.00132	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CRH—alcohol dependence	9.73e-05	0.00132	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ADH6—alcohol dependence	8.87e-05	0.0012	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—DRD4—alcohol dependence	8.5e-05	0.00115	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—POMC—alcohol dependence	8.22e-05	0.00111	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CNR1—alcohol dependence	8.12e-05	0.0011	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HTR7—alcohol dependence	7.92e-05	0.00107	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—DRD2—alcohol dependence	7.92e-05	0.00107	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—POMC—alcohol dependence	7.88e-05	0.00107	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—EP300—alcohol dependence	7.8e-05	0.00106	CbGpPWpGaD
Everolimus—FKBP1A—Disease—EP300—alcohol dependence	7.46e-05	0.00101	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ADH1A—alcohol dependence	7.35e-05	0.000995	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—AVP—alcohol dependence	6.67e-05	0.000903	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ADH4—alcohol dependence	6.25e-05	0.000846	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HTR2A—alcohol dependence	5.55e-05	0.000752	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ADH7—alcohol dependence	5.31e-05	0.00072	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—EP300—alcohol dependence	5.22e-05	0.000708	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GGT2—alcohol dependence	5.09e-05	0.00069	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ADH1B—alcohol dependence	4.66e-05	0.000631	CbGpPWpGaD
Everolimus—MTOR—Immune System—EP300—alcohol dependence	4.54e-05	0.000616	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—POMC—alcohol dependence	4.43e-05	0.0006	CbGpPWpGaD
Everolimus—MTOR—Disease—EP300—alcohol dependence	4.2e-05	0.000569	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—MAOB—alcohol dependence	3.86e-05	0.000523	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ALDH2—alcohol dependence	3.28e-05	0.000445	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—EP300—alcohol dependence	2.94e-05	0.000398	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GOT2—alcohol dependence	2.79e-05	0.000378	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP2E1—alcohol dependence	2.62e-05	0.000355	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GGT1—alcohol dependence	2.41e-05	0.000326	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GOT1—alcohol dependence	2.41e-05	0.000326	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—MAOA—alcohol dependence	2.16e-05	0.000292	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—POMC—alcohol dependence	1.41e-05	0.00019	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—EP300—alcohol dependence	9.32e-06	0.000126	CbGpPWpGaD
